Tags

Type your tag names separated by a space and hit enter

Clinicopathologic presentations of dermatomycoses in cancer patients.
J Eur Acad Dermatol Venereol. 2008 Aug; 22(8):907-17.JE

Abstract

Many of the skin fungal infections in cancer patients may look similar to those infections in non-cancer patients. However, in some cases, they become more extensive and even life threatening. Prolonged and severe neutropenia is the main risk factor for the dramatic issue of fungal infections. The dermatomycoses in cancer patients can be classified in four broad groups: primary superficial dermatophytoses, primary superficial yeast infections, opportunistic mold infections with distinct potential for dissemination and secondary cutaneous manifestations of fungaemia. Occasionally, more than one fungus are found inside a given skin lesion. A special condition is represented by the mycotic colonization of mucosal squamous cell carcinomas. Angio-invasion by fungi accounts for the frequency of disseminated infections prevailing in immunocompromised cancer patients. In case of skin involvement, the dermatologist may assist by recognizing subtle semiological signs and performing biopsies for swift histological examination, molecular biology and/or culture.

Authors+Show Affiliations

Department of Dermatopathology, University Hospital Sart Tilman, Liège, Belgium. pascale.quatresooz@chu.ulg.ac.beNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

18503529

Citation

Quatresooz, P, et al. "Clinicopathologic Presentations of Dermatomycoses in Cancer Patients." Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 22, no. 8, 2008, pp. 907-17.
Quatresooz P, Piérard-Franchimont C, Arrese JE, et al. Clinicopathologic presentations of dermatomycoses in cancer patients. J Eur Acad Dermatol Venereol. 2008;22(8):907-17.
Quatresooz, P., Piérard-Franchimont, C., Arrese, J. E., & Piérard, G. E. (2008). Clinicopathologic presentations of dermatomycoses in cancer patients. Journal of the European Academy of Dermatology and Venereology : JEADV, 22(8), 907-17. https://doi.org/10.1111/j.1468-3083.2008.02774.x
Quatresooz P, et al. Clinicopathologic Presentations of Dermatomycoses in Cancer Patients. J Eur Acad Dermatol Venereol. 2008;22(8):907-17. PubMed PMID: 18503529.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinicopathologic presentations of dermatomycoses in cancer patients. AU - Quatresooz,P, AU - Piérard-Franchimont,C, AU - Arrese,J E, AU - Piérard,G E, Y1 - 2008/05/23/ PY - 2008/5/28/pubmed PY - 2009/8/6/medline PY - 2008/5/28/entrez SP - 907 EP - 17 JF - Journal of the European Academy of Dermatology and Venereology : JEADV JO - J Eur Acad Dermatol Venereol VL - 22 IS - 8 N2 - Many of the skin fungal infections in cancer patients may look similar to those infections in non-cancer patients. However, in some cases, they become more extensive and even life threatening. Prolonged and severe neutropenia is the main risk factor for the dramatic issue of fungal infections. The dermatomycoses in cancer patients can be classified in four broad groups: primary superficial dermatophytoses, primary superficial yeast infections, opportunistic mold infections with distinct potential for dissemination and secondary cutaneous manifestations of fungaemia. Occasionally, more than one fungus are found inside a given skin lesion. A special condition is represented by the mycotic colonization of mucosal squamous cell carcinomas. Angio-invasion by fungi accounts for the frequency of disseminated infections prevailing in immunocompromised cancer patients. In case of skin involvement, the dermatologist may assist by recognizing subtle semiological signs and performing biopsies for swift histological examination, molecular biology and/or culture. SN - 1468-3083 UR - https://www.unboundmedicine.com/medline/citation/18503529/Clinicopathologic_presentations_of_dermatomycoses_in_cancer_patients_ L2 - https://doi.org/10.1111/j.1468-3083.2008.02774.x DB - PRIME DP - Unbound Medicine ER -